This study aims to describe the initial experiences and immediate outcomes of percutaneous coronary intervention (PCI) in patients with significant left main coronary artery disease with normal LV function in National Institute of Cardiovascular Diseases (NICVD), Dhaka. Left main coronary artery disease is regarded as an absolute contraindication for coronary angioplasty. Recently several reports on protected or unprotected LMCA stenting or both suggested the possibility of percutaneous intervention for this prohibited area. The study was conducted in National Institute of Cardiovascular diseases & Hospital, Dhaka, Bangladesh. Participants of the study were 100 patients with a diagnosis of critical left main coronary artery disease. Information was collected on their demographic characteristics and clinical history. Relevant physical examination and laboratory investigation were performed. Percutaneous transluminal coronary angioplasty (PTCA) with stent implantation were done in the left main coronary artery and other culprit vessel where required. They were followed up thoroughly during the hospital stay. The study subjects were from 35 to 70 years old. 70 male and 30 female were included in this study. According to the clinical history, 12 lead surface ECG reading and cardiac enzyme analysis 40% patient was diagnosed as unstable angina, 40% presented with chronic stable angina and rest of them presented with old myocardial infarction. Among the study population critically isolated LM disease were 30%, critical left main with other vessels disease were 70%. The pattern of LM disease involvement were osteal 40%, mid shaft 10%, distal bifurcation 30%, entire LM involving bifurcation 20%. Procedural success rate was 100%. No patient faced major advance cardiac events (MACE) during hospital stay. Stenting of unprotected LM coronary artery stenosis may be safe effective alternative to CABG in carefully selected patients with normal LV function. Further studies in larger population of this group are needed to assess late out comes.
no data is available as to measure the safety & efficacy of stenting in UPLM disease in our country. So we have taken the imitative 1 st time in a small scale to measure the immediate outcome of PCI in UPLM disease. The objective of this study is to determine whether stenting of UPLM coronary stenoses is safe in selected patient and thus may provide an alternative to CABG.
Methods:
From January 2012 to April 2014, a total of 100 consecutive patients with significant unprotected LMCA stenoses who declined CABG were treated with stent implantation in the department of cardiology, NICVD, Dhaka, Bangladesh.
Inclusion criteria: Patient with unstable angina, chronic stable angina & old myocardial infarction who had significant left main coronary artery disease (>50% diameter stenoses of left main artery) with or without other coronary involvement.
Exclusion criteria: 1) Contra indication to aspirin or clopidogrel.
2) Patient with surgery indicated for valvular heart disease. In addition to significant LMCA stenosis, significant narrowing of other coronary arteries were also stented at the same time. All patients gave written informed consent to participate in this study. Pre dilatation before stent implantation was performed with undersized, conventional angioplasty balloons. The stent was then deployed by inflating the stent delivery balloon at nominal pressure. After deployment of the stent, stented segment were further dilated with high pressure balloon inflation, to achieve angiographic optimization.
The balloon inflation were brief (<30sec) and multiple (>3) to avoid prolonged ischemia & ischemia related complications. The size of the stent was >3.5mm in all LM lesions. The lesions at the ostium or shaft without involvement of the distal bifurcation comprised 70% of the lesion. The stents used to treat all LMCA lesion was drug eluting stent. During the procedure, patients received a 10,000-U bolus of heparin with a repeat bolus of 5000 U every 30 minutes to maintain a activated clotting time of >300 sec. All patient were kept in the coronary care unit (CCU) for 24 hour and later shifted to coronary step down unit before discharge. All patients received loading dose of 300mg aspirin & 600mg clopidogrel before the procedure. After the procedure all patients were maintained with 150mg aspirin & 75mg of clopidogrel per day for at least one year. Other pharmacological treatment (eg statin, angiotensin converting enzyme inhibitors, beta blockers) were recommended based on current practice. Primary end point was in-hospital mortality, Q wave MI & repeat revascularizations. 
Results:
A total of 100 patients with coronary artery disease who underwent coronary angiogram and found critical stenosis in LM coronary artery with or without involvement of other three vessels and underwent reperfusion therapy with PTCA were studied. Their mean age was 53.1±12.6 years. The most common age group was 51-60 years (37.5%) 30% of them were female and 70% were male. Cigarette smoking was the most common risk factor, found in 50(50%) of study patients.
Other risk factors were diabetes mellitus in 30(30%) patients, Hypertension in 40(40%) patients and dyslipidemia in 24(24%) patients. A family history of coronary artery disease (CAD) was found in 20% of patients, 20% had a history of a myocardial infarction, and none had undergone a previous PCI and none had heart failure. We also try to classify different position of involvement of the left main artery disease. Osteal involvement was PTCA was done by using drug eluting stents. In most of the cases (90%) a single stent was sufficient. 10% needed double stents to cover the entire length of the left main coronary artery. All osteal, osteal with mid shaft, entire left main lesions were covered with a single stent. 20 of the patients with distal bifurcation involvement needed single stent but 10 patients with distal bifurcation needed double stent.
Discussion:
The LMCA is of importance as it supplies approximately two-thirds of the blood to the heart and almost 100% of the blood flow to the left ventricle. As a result severe LMCA disease will reduce flow in a large portion of the myocardium placing the patient at a risk for life threatening events of LV dysfunction and arrhythmia 17 . The LMCA differs from the other coronary arteries by its relatively greater elastic tissue content which can explain elastic recoil and high restenosis rate following balloon angioplasty 18 . Atherosclerotic lesions tend to form at specific regions of the coronary vasculature where flow is disturbed, particularly in area of low shear stress 19 . In the LMCA bifurcation, intimal atherosclerosis is accelerated primarily in area of low shear stress in the lateral well close to the LAD & LCX bifurcation. Thus the carena is frequently free of disease and this can explain the reason why single stent strategy (Provisional stenting) can be successfully performed in patient with no or moderate disease by angiography. Plaque shift and incomplete stent expansion are important technical consideration when thinking about stenting the LM.
Because of concern about procedural risk & long term durability, PCI has usually been restricted to patients who are poor candidates for surgery or have LMCA disease that is protected by a patent bypass graft to the left anterior descending or circumflex artery. The European guidelines for PCI stated that stenting for unprotected LMCA disease should only be considered in the absence of other revascularization options 20 . Likewise, the American guideline writing committee considered coronary artery bypass grafting as the gold standard for revascularization of lesions in the LMCA in patients eligible for CABG given the proven benefit in the long term 21 . However some cardiac interventionists feel that these guidelines do not take in to account the advances in stent technology and development of antiplatelet regimens which have minimized the incidence of acute & sub acute stent thrombosis and restenosis 22 . It is necessary therefore to examine the evidence for LMCA stenting.
Balloon angioplasty of unprotected LMCA stenosis has been associated with varying degree of procedural success, but generally poor long term prognosis [23] [24] [25] [26] . Previously reported unprotected LMCA stent procedures have been done in conditions of prohibitive surgical risk or in bailout situations [27] [28] [29] [30] [31] [32] . Other investigators have reported primarily protected LMCA stenting [33] [34] [35] . The current study indicates that stenting of LMCA stenosis improves both the immediate procedural success and long term clinical outcomes compared with balloon angioplasty, in part because of the low sub-acute stent thrombosis rate using optimal stent implantation techniques 36 & new antiplatelet agent 37 . Most of the procedures in the current study were elective; all patient had normal LV function; and balloon inflations were intentionally kept short in duration. These facts may explain the high procedural success rate.
Our study shows excellent procedural success rate (100%) with an excellent overall in-hospital survival rate (100%). A total of 100 patients were selected non randomizedly considering the exclusion and inclusion criteria. All the lesions were predilated with balloon. All the patient were stented with drug eluting stent. Post dilatation was done in all cases with high pressure balloon.
Osteal and mid shaft lesions were managed as stenting in other main coronary arteries, but distal bifurcation lesions had some sorts of technical challenges.
In our study 30 patients had distal bifurcation lesion. Among these 30 cases 20 was managed with single stent strategy, out of this 20, four needed kissing balloon angioplasty. Rest 10 distal bifurcation lesions were managed with double stent strategy with a distribution of crush technique for 6 cases, T stenting for two cases, culotte stenting for two cases.
No patient developed any periprocedural major or minor adverse cardiac events like anginal chest pain, arrhythmias, University Heart Journal Vol. 10, No. 1, January 2014 cardiac arrest, cardiogenic shock, Q-wave MI, repeat revascularization and death during their hospital stay. So in this study our procedural success & in-hospital survival rate was excellent (100%). Main limitation of this study was lacking of IVUS to assess exact placement and optimal expansion of the stent which is especially important for distal bifurcation lesion to ensure adequate coverage of the lesion. Despite this limitation our study shows that stenting of unprotected LMCA stenosis is a safe and effective revascularization procedure in a carefully selected patient group with preserved LV function.
Conclusion:
This study result shows that despite the limited facility and financial limitations in Bangladesh, patients who underwent PCI in left main coronary artery had good inhospital outcomes, nearly similar to outcomes seen in studies conducted in other countries. Thus, PCI may be the preferred reperfusion strategy for the management of critical left main coronary artery intervention in the current Bangladesh setting.
Our future perspective is to establish the comparison of survival outcome in ULMCA stenting versus CABG in our patient population. Further study is also required to assess the long term outcome in ULMCA stenting.
